FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Emedastine Difumarate (Emadine) 0.05% Ophthalmic Solution
Status: Discontinuation
»Therapeutic Categories: Ophthalmology; Pulmonary/Allergy

Novartis (New 01/29/2019)

Company Contact Information:

Presentation Posting Date Related Information
Emadine (emedastine difumarate) 0.05% ophthalmic solution 5mL in 1 Bottle (NDC 0065-0325-05) 01/29/2019 Novartis Pharmaceuticals has made a business decision to permanently discontinue this product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English